As the 21st century continues to evolve in its technology and data driven insights, the healthcare industry is finding itself having to evolve with it at an increasing rate of speed. As we have seen over the last decade or so, the need for prescribers to have the ability to electronically send accurate, error-free and understandable prescriptions to the pharmacy from the point of care has grown dramatically in effort to improve the quality of patient care. So much so that e-prescribing has undergone major regulatory changes, including federal and state governments passing new mandates for Electronic Prescriptions for Controlled Substances (EPCS). In addition to federal regulation 42 CFR § 423.160, which requires that all EPCS are to be transmitted electronically for all Medicare Part D and Medicare Advantage prescription drug plans as of January 1, 2023, most U.S. states have already enacted or have proposed mandates for e-prescribing controlled medications in place; in some cases, such as California or New York, requirements are now in effect to require all prescriptions to be transmitted electronically. As healthcare providers navigate the federal and state regulatory changes regarding e-prescribing, it is equally critical to understand and leverage the data behind prescriptions being sent electronically to improve the quality of patient care and the overall success of the 340B program.
Expanding the Horizon: Utilizing e-Prescribe and Switch Data for 340B Program Enhancement
In the realm of 340B program management success, the ability to harness meaningful data is pivotal. Leveraging the incorporation of e-Prescribe and switch data adds a new dimension to optimizing program benefits. These data sources offer a unique opportunity for covered entities to create a comprehensive heat map of valuable dispensing pharmacies, enhancing contract pharmacy opportunities, and refining patient care strategies.
More specifically, the convergence of e-Prescribe and switch data in the realm of 340B program management introduces a transformative approach to optimizing program benefits. By creating a heat map that showcases prescription filling pharmacies and patient-prescriber-pharmacy interactions, covered entities can strategically expand contract pharmacy opportunities and refine patient care strategies to improve their patient’s quality of care. This data-driven approach not only enhances program effectiveness but also underscores the commitment of covered entities to delivering accessible, affordable, and patient-centered healthcare services to underserved populations.
Stay tuned for Part 2 of Harnessing the Power of Data to Improve Quality Patient Care, available in early June.
For more information regarding data analytics, reporting, and other consultation services – please follow us on LinkedIn or reach out to [email protected].